The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...

Co., Inc. (NYSE:MRK), recently purchased 2,832.861 shares of the company's common stock. The acquisition, valued at approximately $249,999, was completed at a price of $88.25 per share. Following this ...

Klaus joins Epitopea after serving as Chief Development Officer (CDO) at Nykode Therapeutics, where he oversaw clinical development, regulatory affairs, and project management across oncology, ...

Whether improving the quality of life or the quality of our environment, life and health science students really do make a difference. Well-established links with government agencies, public bodies, ...

A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...

The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.

MSNBC’s Lawrence O’Donnell remembers the legacy of Cecile Richards, longtime president of Planned Parenthood and frequent guest of The Last Word who dedicated her life to fighting to protect ...

Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck ... and other cancers later in life. The arrangement with Wisner ...

"We have previously had two well-established types of magnetism," study author Oliver Amin, a postdoctoral researcher at the University of Nottingham in the U.K., told Live Science ...

So what does science have to say? Though some are identified as balloons or drones, weather phenomena, or optical illusions, others remain mysterious. Could they be the result of secret new ...

Merck, Bristol Myers Squibb, Novartis, AstraZeneca and Amgen are all facing significant patent losses over the next five years, according to analysis by healthcare investment bank Leerink.